Sugammadex Update

Specialties CRNA

Published

Specializes in Anesthesia.

"Arfaei said he expects U.S. approval of sugammadex by the second quarter of 2014 and forecast worldwide sales of $574 million in 2015.

The drug is already approved in 50 countries, including Japan."

http://medcitynews.com/2013/09/fda-notifies-merck-concerns-sugammadex-drug-study/

Maybe this explains why there is currently a "shortage" of glyco that our pharmacy can only get through one "black-market" type of distributor for...get this...$600.00 for a box of 20 1cc vials! There has to be some kind of law being trampled on here. Anyhoo, this news goes a long way toward explaining the current shortage.

Specializes in Anesthesia.
Maybe this explains why there is currently a "shortage" of glyco that our pharmacy can only get through one "black-market" type of distributor for...get this...$600.00 for a box of 20 1cc vials! There has to be some kind of law being trampled on here. Anyhoo, this news goes a long way toward explaining the current shortage.

It must be a regionally shortage. We haven't experienced any problems with shortages of glyco, yet...

Specializes in SICU / Transport / Hyperbaric.

We were also told that we had a recent shortage.

Specializes in Anesthesia.
We were also told that we had a recent shortage.

That will be something to look forward to. It seems to take us a couple months lag time to see the shortages here in Alaska and then it takes a couple of months longer to see them resolved than the rest of the US.

+ Add a Comment